Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
Open Access
- 15 February 2007
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 8 (3) , 275-278
- https://doi.org/10.1038/sj.gene.6364377
Abstract
Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have inflammatory bowel disease (IBD), the majority ulcerative colitis (UC). An inherent problem in interpreting positive findings in genetic association studies of PSC is thus to distinguish between factors associated with hepatobiliary versus intestinal pathology. We aimed to clarify to what extent human leukocyte antigen (HLA) class II associations in UC patients with and without PSC differ. High-resolution DRB1 and DQB1 typing was performed in 365 Scandinavian PSC patients, an independent cohort of 330 Norwegian UC patients and 368 healthy controls. HLA associations found in PSC were mostly distinct from those seen in UC, and no significant differences were noted between PSC patients with concurrent UC and PSC patients without IBD. This suggests different HLA associated genetic susceptibility to PSC and UC, and supports notions that UC in PSC may represent a distinct UC phenotype.Keywords
This publication has 21 references indexed in Scilit:
- New genes in inflammatory bowel disease: lessons for complex diseases?The Lancet, 2006
- Genetics of inflammatory bowel disease: The role of the HLA complexWorld Journal of Gastroenterology, 2006
- Review article: current management of primary sclerosing cholangitisAlimentary Pharmacology & Therapeutics, 2005
- Increased prevalence of primary sclerosing cholangitis among first-degree relativesJournal of Hepatology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countriesScandinavian Journal of Gastroenterology, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Epidemiology of primary sclerosing cholangitisBest Practice & Research Clinical Gastroenterology, 2001
- Hepatobiliary Complications of Inflammatory Bowel DiseaseSeminars in Liver Disease, 1988
- Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.Gut, 1980